ZBIO · Zenas BioPharma, Inc.
$32.32
+0.70 (+2.21%)
At close · Aug 21
Market Cap
$2.06B
Shares
65.18M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-10 | — | $200,000,000 | — | — | 10-K , filed 2026-03-16 |
Key facts
CIK
1953926
CUSIP
98937L105
13F (30d)
140 filings
139 filers
Visit website
Investor relations